Expert Opinion on Emerging Drugs

853 papers and 15.0k indexed citations i.

About

The 853 papers published in Expert Opinion on Emerging Drugs in the last decades have received a total of 15.0k indexed citations. Papers published in Expert Opinion on Emerging Drugs usually cover Molecular Biology (186 papers), Oncology (170 papers) and Pulmonary and Respiratory Medicine (137 papers) specifically the topics of Lung Cancer Treatments and Mutations (29 papers), Chronic Lymphocytic Leukemia Research (27 papers) and Asthma and respiratory diseases (26 papers). The most active scholars publishing in Expert Opinion on Emerging Drugs are Jens J. Holst, Erik De Clercq, David R. Janero, Ruth A. Duffy, Len Neckers, David J. Hunter, Walter J. Lukiw, Gordon S. Lynch, Kang Choon Lee and Alexandros Makriyannis.

In The Last Decade

Fields of papers published in Expert Opinion on Emerging Drugs

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Expert Opinion on Emerging Drugs. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Expert Opinion on Emerging Drugs

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Expert Opinion on Emerging Drugs. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Expert Opinion on Emerging Drugs with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025